The 18-month publication provisions of the American Inventors Protection Act of 1999 will take effect later this year 1. With certain exceptions, any patent application filed or pending in the US on ...
SOMERSET, N.J.--(BUSINESS WIRE)--Legend Biotech Corporation (NASDAQ: LEGN), a global, clinical-stage biotechnology company developing and manufacturing novel therapies, announced today the submission ...
Dublin, Oct. 16, 2025 (GLOBE NEWSWIRE) -- The "Applications of Nanoparticles in the Pharmaceutical and Biomedical Industries Training Course (Nov 12th - Nov 13th, 2025)" has been added to ...
The National Committee on Biosafety of the Philippines (NCBP) and the Advanced Science and Technology Institute (ASTI) held ...
PITTSBURGH, Nov. 27, 2023 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS), a commercial-stage biotechnology company focused on the discovery, development and commercialization ...
BEIJING, Nov. 15, 2021 /PRNewswire/ -- HebaBiz Biotech is pleased to announce that in November 2021, the Center for Drug Evaluation (CDE) of The National Medical Products Administration (NMPA) of ...
GlaxoSmithKline (GSK) today announced the submission of a new drug application to the US Food and Drug Administration and new data from two Phase III trials for Rezonic TM /Zunrisa TM (casopitant), a ...
LONDON--(BUSINESS WIRE)--According to a recent Technavio report, the blue biotechnology market is expected to grow by USD 1.77 billion during 2019-2023. Growth in the blue biotechnology market can be ...
PRINCETON, N.J., Sept. 13, 2023 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (PDS Biotech or Company), a clinical-stage immunotherapy company developing a growing pipeline of ...
Merck to Pay ARIAD $25 Million Milestone Payment for Acceptance of Filing WHITEHOUSE STATION, N.J. & CAMBRIDGE, Mass., Aug. 18, 2011 -- Merck (NYSE:MRK), known outside the United States and Canada as ...
New research to better understand how bacteria and their viruses interact and evolve will enable future studies to exploit the use of bacteria and their viruses for potential biotechnology and health ...